InspireSport record month for bookings

Calculus Capital’s portfolio company InspireSport have recorded a record-breaking month for tour bookings. Steve Butchart, CEO, InspireSport: “It’s been a record breaking two months for inspiresport. November was the biggest single booking month for the company since its formation in … Continued

Calculus Capital invests £3m in Jumptastic

London, 15 December 2016: Private equity fund manager and Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist Calculus Capital has invested £3m in UK trampoline park company Jumptastic as it plans to expand into Scandinavia. Jumptastic’s highly successful first … Continued

VCTs slash fundraising levels

John Glencross, CEO of Calculus Capital is cited in the FT’s latest VCT article. Investors face missing out on lucrative tax breaks as popular venture capital trusts cut yearly fundraising levels, warn wealth managers. Jason Hollands, managing director at Tilney … Continued

Venn Life Sciences wins new contract worth EUR2.5m

Venn Life Sciences has signed a new contract worth €2.5m with Sedana Medical for a phase III trial. The trial, which is confined to patients in Germany and commences immediately, will confirm the efficacy and safety of sedation with isoflurane … Continued

Premaitha Welcomes UK Govt. Decision

NHS to adopt NIPT for high risk women Manchester, UK – 31 October 2016: Premaitha Health plc (AIM: NIPT), developer of the leading CE-marked complete non-invasive prenatal screening system, welcomes the decision by the UK’s Department of Health to make … Continued

Arcis launches easy-to-use DNA extraction blood kit

The Liverpool Echo cover Arcis Biotechnology’s latest development: A Daresbury bio-tech firm has announced the launch of a kit for preparing DNA extracted from blood. Arcis Biotechnology said the process takes three minutes and uses a novel two-step system sold … Continued